Taro Pharmaceutical Industries Ltd. revenue for the last year amounted to 629.18 M USD, the most of which — 389.61 M USD — came from its highest performing source at the moment, Dermatological and Topical, the year earlier bringing 336.81 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Taro Pharmaceutical Industries Ltd. 363.06 M USD, and the year before that — 376.68 M USD.